Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir

Am J Transplant. 2005 Jul;5(7):1781-2; author reply 1783. doi: 10.1111/j.1600-6143.2005.00936.x.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Aged
  • Antiviral Agents / therapeutic use*
  • Cytomegalovirus Infections / drug therapy*
  • Cytomegalovirus Infections / etiology*
  • Female
  • Ganciclovir / analogs & derivatives*
  • Ganciclovir / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Organ Transplantation / adverse effects*
  • Valganciclovir

Substances

  • Antiviral Agents
  • Valganciclovir
  • Ganciclovir